undamentalytics Newsletter

Astrotech Corp (ASTC) stock

Add holding +

NASDAQ: ASTC Nasdaq Life Sciences Tools & Services Next results ~December 24, 2026

Astrotech Corp is a US-listed company in the life sciences tools & services industry. Its financial year ends in June.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds7 adding, 8 cuttingOf 0 active managers that changed their stake, 0 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Astrotech files

Where Astrotech stands after its latest 10-K

Astrotech has little or no product revenue yet; it used $14m of cash in the twelve months to June 2026. The diluted share count is up 2.1% on a year earlier, which dilutes existing holders. It passes 2 of our 2 financial-health checks.

Our model value for Astrotech is under review, so past values are not shown until it is resolved.

Source: 10-K filed September 25, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~December 24, 2026 (estimated)

Astrotech Corp's trailing-twelve-month revenue grew 62.2% year on year, with a free-cash-flow margin of -842.6%.

Current signal Revenue growth accelerating: TTM revenue growth rose to 62.2% (+54.8pp vs the prior quarter).

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Strengths

  • Fast growth. Revenue grew 62.2% over the last 12 months.
  • Growth speeding up. The growth rate is 54.8 points higher than a quarter earlier.
  • Margins widening. Operating margin is up 573.4 points on a year ago.
  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Loss-making. Operating margin is -831.2%: costs exceed revenue.
  • Burning cash. Free cash flow was -842.6% of revenue over the last 12 months.
  • Heavy stock-based pay. Stock pay equals 54.1% of revenue: a real cost that cash-flow figures leave out.
  • Share dilution. Diluted shares rose 2.1% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 500% and a beta of 1.2 against the S&P 500.
  • Gross margin slipping. Gross margin is down 32.5 points on a year ago.

Latest results: FY2026 Q4

Filed September 25, 2026
Earnings per share
-$19.50 against an average estimate of -$18.00: missed by 8.3%
Revenue
$1m, up 315.0% on a year earlier
Share reaction
+6.4% in the first session after the results on September 25, 2026, against -0.2% for the S&P 500

Astrotech's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-2.7%
  • 1 week-6.0%
  • 1 month-33.3%
  • This year+36.1%
  • 1 year+21.7%
  • 5 years-85.2%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$1.7M
Operating margin
-831.2%
Net margin
-848.1%
EPS (TTM, diluted)
$-8.49

Growth

Revenue growth
+62.2%
Change in growth rate
+54.8 pts
Share count change
+2.1%

Cash

Free cash flow (TTM)
-$14.3M
FCF margin
-842.6%
Stock pay % of revenue
54.1%

Earnings

Last results
September 25, 2026
Next results (est.)
December 24, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Leadership
  2. Results
  3. Announcement
  4. Leadership

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: data-quality checks not passed.

Valuation multiples over time Market data may be delayed

Astrotech Corp: market value and multiples by fiscal year
At fiscal year end 20162017201820192020202120222023202420252026
Share price$253.50$136.50$93.00$75.00$85.50$39.90$12.90$14.16$8.90$5.78$10.91
Market value$34m$19m$13m$12m$18m$29m$21m$23m$15m$10m$19m
+ Net debt (− = net cash)−$4m−$2m−$552000−$2m−$3m−$35m$0$0$0−$3m−$8m
Enterprise value$30m$16m$12m$11m$15m−$6m$21m$23m$15m$7m$10m
Multiples
Price / sales 12.9x8.0x146.4x97.2x37.1x87.5x23.6x30.6x8.6x9.6x20.3x
Price / earnings ———————————
Price / free cash flow ———————————
EV / EBITDA ———————————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

9 /100

Weak moat

How hard Astrotech's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -30.5% of total assets over 10 years.

  • Pricing power 5 / 20

    Gross margin has been a median 35.0%, moving by 16.6 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -1439.7%; its worst year was -15508.1%.

  • Cash conversion 0 / 20

    Free cash flow was positive in 0 of 10 years, at a median -1288.3% of revenue.

  • Discipline 0 / 20

    The diluted share count rose 932.4% over five years; stock-based pay has been a median 131.8% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (14 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

No analyst estimates are published for Astrotech Corp: too few analysts cover it.

Earnings against estimates

Astrotech Corp: reported EPS against the consensus estimate
Quarter toEstimateActualSurprise
Dec 2016 −$18.00 −$19.50 −8.3%
Sept 2016 −$24.00 −$25.50 −6.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, September 25, 2026

No numeric guidance in Astrotech Corp's latest earnings release (filed September 25, 2026). Some companies give their outlook only on the earnings call.

Positioning

Short interest
3.0%
of tradable shares
Days to cover
1.73
at average volume
Short interest, 1 month
−40%
to October 15, 2026
Held by institutions
10%
of shares
Held by insiders
10.2%
of shares
Employees
28
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +21.7%

$3.87 on October 31, 2025 to $4.71

Astrotech Corp: share-price change split into its parts
PartThenNowEffect
Revenue (last 12 months) $1m $2m +62.2%
P/S multiple 6.1x 4.7x −23.4%
Share count 2m 2m −2.1%

Biggest factor: revenue. Loss-making at one end, so the split uses price/sales.

Last 3 years −50.4%

$9.50 on November 3, 2023 to $4.71

Astrotech Corp: share-price change split into its parts
PartThenNowEffect
Revenue (last 12 months) $750000 $2m +126.8%
P/S multiple 20.5x 4.7x −77.1%
Share count 2m 2m −4.7%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Astrotech Corp: yearly return, monthly win rate and worst fall against the S&P 500
Calendar year 202120222023202420252026 to date
Return
ASTC−62%−51%−15%−21%−49%+36%
Industry peers (median)+5%−53%−3%−13%−2%+15%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
ASTC33%33%50%42%8%36%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
ASTC−84%−59%−51%−42%−62%−91%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 99% from March 9, 2016 to March 26, 2026. Getting back needed a 16352% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$2.17 – $49.80
From 52-week high
−90.5%
vs 50-day average
−26.9%
vs 200-day average
−34.7%
Volatility (1 year)
500%
Beta vs S&P 500
1.23

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
2 up, 10 down
typical move ±2.8%
After a week
1 up, 11 down
typical move ±4.9%
After a month
4 up, 8 down
typical move ±57.9%
Astrotech Corp: share-price change after each results release
Results releasedNext dayS&P 500 next day5 days21 days
September 25, 2026 +6.4% −0.2% −1.7% −30.2%
May 13, 2026 −3.3% +1.4% −11.9% +604.1%
February 13, 2026 −3.1% +0.2% −2.8% −16.6%
November 13, 2025 −0.3% −1.7% −12.5% +5.8%
September 25, 2025 −2.7% +0.1% −6.4% −21.0%
May 13, 2025 0.0% +0.8% −1.2% −3.9%
February 14, 2025 +2.9% +0.3% −6.9% −1.8%
November 12, 2024 −3.6% −0.3% −0.3% −6.5%
September 19, 2024 −5.9% +1.5% −1.5% +0.7%
May 13, 2024 −2.5% +0.5% +4.2% −1.9%
February 12, 2024 −2.4% −1.4% −8.4% −1.2%
November 13, 2023 −0.8% +1.8% −1.3% +1.2%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Astrotech Corp
$0 $1M $2M $3M FY24 Q1 FY24 Q4 FY25 Q3 FY26 Q4 Revenue (TTM), FY24 Q1: $1.1M Revenue (TTM), FY24 Q2: $2M Revenue (TTM), FY24 Q3: $2M Revenue (TTM), FY24 Q4: $1.7M Revenue (TTM), FY25 Q1: $1.3M Revenue (TTM), FY25 Q2: $455K Revenue (TTM), FY25 Q3: $939K Revenue (TTM), FY25 Q4: $1M Revenue (TTM), FY26 Q1: $1.3M Revenue (TTM), FY26 Q2: $1.2M Revenue (TTM), FY26 Q3: $1M Revenue (TTM), FY26 Q4: $1.7M $1.7M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY24 Q1 $1.1M
FY24 Q2 $2M
FY24 Q3 $2M
FY24 Q4 $1.7M
FY25 Q1 $1.3M
FY25 Q2 $455K
FY25 Q3 $939K
FY25 Q4 $1M
FY26 Q1 $1.3M
FY26 Q2 $1.2M
FY26 Q3 $1M
FY26 Q4 $1.7M
Revenue growth, TTM YoY Astrotech Corp
-200% 0% 200% 400% 600% FY24 Q1 FY24 Q4 FY25 Q3 FY26 Q4 Revenue growth, TTM YoY, FY24 Q1: 57.9% Revenue growth, TTM YoY, FY24 Q2: 371.3% Revenue growth, TTM YoY, FY24 Q3: 456.7% Revenue growth, TTM YoY, FY24 Q4: 126.7% Revenue growth, TTM YoY, FY25 Q1: 15.1% Revenue growth, TTM YoY, FY25 Q2: -77.1% Revenue growth, TTM YoY, FY25 Q3: -53.1% Revenue growth, TTM YoY, FY25 Q4: -38.3% Revenue growth, TTM YoY, FY26 Q1: 0.2% Revenue growth, TTM YoY, FY26 Q2: 163.5% Revenue growth, TTM YoY, FY26 Q3: 7.3% Revenue growth, TTM YoY, FY26 Q4: 62.2% 62.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY24 Q1 57.9%
FY24 Q2 371.3%
FY24 Q3 456.7%
FY24 Q4 126.7%
FY25 Q1 15.1%
FY25 Q2 -77.1%
FY25 Q3 -53.1%
FY25 Q4 -38.3%
FY26 Q1 0.2%
FY26 Q2 163.5%
FY26 Q3 7.3%
FY26 Q4 62.2%
Operating margin (TTM) Astrotech Corp
-4000% -3000% -2000% -1000% 0% FY24 Q1 FY24 Q4 FY25 Q3 FY26 Q4 Operating margin (TTM), FY24 Q1: -1023.0% Operating margin (TTM), FY24 Q2: -597.5% Operating margin (TTM), FY24 Q3: -632.1% Operating margin (TTM), FY24 Q4: -781.2% Operating margin (TTM), FY25 Q1: -1036.9% Operating margin (TTM), FY25 Q2: -3258.5% Operating margin (TTM), FY25 Q3: -1614.5% Operating margin (TTM), FY25 Q4: -1404.6% Operating margin (TTM), FY26 Q1: -1116.0% Operating margin (TTM), FY26 Q2: -1186.2% Operating margin (TTM), FY26 Q3: -1369.8% Operating margin (TTM), FY26 Q4: -831.2% -831.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY24 Q1 -1023.0%
FY24 Q2 -597.5%
FY24 Q3 -632.1%
FY24 Q4 -781.2%
FY25 Q1 -1036.9%
FY25 Q2 -3258.5%
FY25 Q3 -1614.5%
FY25 Q4 -1404.6%
FY26 Q1 -1116.0%
FY26 Q2 -1186.2%
FY26 Q3 -1369.8%
FY26 Q4 -831.2%
FCF margin (TTM) Astrotech Corp
-3000% -2000% -1000% 0% FY24 Q1 FY24 Q4 FY25 Q3 FY26 Q4 FCF margin (TTM), FY24 Q1: -858.0% FCF margin (TTM), FY24 Q2: -483.1% FCF margin (TTM), FY24 Q3: -466.8% FCF margin (TTM), FY24 Q4: -606.1% FCF margin (TTM), FY25 Q1: -848.7% FCF margin (TTM), FY25 Q2: -2751.4% FCF margin (TTM), FY25 Q3: -1473.4% FCF margin (TTM), FY25 Q4: -1314.1% FCF margin (TTM), FY26 Q1: -1089.2% FCF margin (TTM), FY26 Q2: -1241.1% FCF margin (TTM), FY26 Q3: -1461.4% FCF margin (TTM), FY26 Q4: -842.6% -842.6%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY24 Q1 -858.0%
FY24 Q2 -483.1%
FY24 Q3 -466.8%
FY24 Q4 -606.1%
FY25 Q1 -848.7%
FY25 Q2 -2751.4%
FY25 Q3 -1473.4%
FY25 Q4 -1314.1%
FY26 Q1 -1089.2%
FY26 Q2 -1241.1%
FY26 Q3 -1461.4%
FY26 Q4 -842.6%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Astrotech Corp: annual financial statements
Fiscal year 2011 Jun 2011 2012 Jun 2012 2013 Jun 2013 2014 Jun 2014 2015 Jun 2015 2016 Jun 2016 2017 Jun 2017 2018 Jun 2018 2019 Jun 2019 2020 Jun 2020 2021 Jun 2021 2022 Jun 2022 2023 Jun 2023 2024 Jun 2024 2025 Jun 2025 2026 Jun 2026
Income
Revenue 20 26 24 0 1 3 2 0 0 0 0 1 1 2 1 1
Gross profit 6 7 8 0 0 0 1 0 0 0 0 0 0 1 0 0
EBITDA −3 −0 2 −10 −16 −13 −11 −13 −8 −8 −8 −8 −11 −13 −14 −13
Operating income −6 −2 −1 −10 −16 −14 −12 −13 −8 −8 −8 −9 −11 −13 −15 −14
Net income −5 −3 −0 −5 11 −13 −12 −13 −8 −8 −8 −8 −10 −12 −14 −14
Diluted EPS −$42.00 −$22.50 $1.50 $37.50 $78.00 −$19.20 −$85.20 −$97.80 −$45.90 −$39.30 −$10.50 — — — — —
Growth (year on year)
Revenue — +29.7% −8.2% −99.5% +294.6% +420.7% −12.8% −96.3% +47.7% +284.3% −31.6% +160.2% −13.7% +126.7% −41.2% −8.7%
EBITDA — — — −754.1% — — — — — — — — — — — —
Net income — — — — — −221.5% — — — — — — — — — —
Diluted EPS — — — — — −124.6% — — — — — — — — — —
Margins
Gross margin 32.2% 28.1% 34.6% 100.0% 17.3% 12.7% 44.5% 58.1% 29.1% 8.0% 10.8% 22.1% 40.8% 44.2% 47.5% 23.8%
EBITDA margin −17.1% −0.2% 6.5% <−999% <−999% −495.6% −487.5% <−999% <−999% <−999% <−999% −961.9% <−999% −738.2% <−999% <−999%
Operating margin −28.6% −8.8% −2.3% <−999% <−999% −518.1% −518.0% <−999% <−999% <−999% <−999% −989.1% <−999% −781.2% <−999% <−999%
Net margin −24.7% −10.4% −0.8% <−999% >999% −490.3% −497.5% <−999% <−999% <−999% <−999% −958.6% <−999% −686.2% <−999% <−999%
Free-cash-flow margin 42.0% −20.5% −19.8% −540.0% <−999% −529.1% −400.3% <−999% <−999% <−999% <−999% −850.2% <−999% −606.1% <−999% <−999%
Cash flow
Cash from operations 9 −4 −3 −1 −11 −13 −9 −11 −8 −7 −7 −7 −8 −10 −13 −13
Capital spending 1 1 2 0 2 1 0 0 0 0 0 1 2 1 1 1
Free cash flow 8 −5 −5 −1 −13 −14 −9 −11 −8 −7 −8 −7 −9 −10 −14 −14
Stock-based pay 1 1 0 1 5 1 1 0 0 0 1 2 1 1 1 1
Free cash flow after stock pay 7 −6 −5 −1 −18 −15 −10 −11 −9 −7 −8 −9 −11 −12 −15 −15
Balance sheet
Cash 15 10 5 4 2 4 2 1 2 3 36 — — — 3 8
Total debt 7 6 6 6 0 0 0 0 0 1 1 0 0 0 0 0
Net debt (negative = net cash) −8 −4 1 2 −2 −4 −2 −1 −2 −3 −35 — — — −3 −8
Diluted shares — — — — — — — — — — — 2m 2m 2m 2m 2m
Returned to shareholders
Buybacks — — — 0 2 0 1 0 0 0 — 0 0 0 — —
Total returned — — — 0 2 0 1 0 0 0 — 0 0 0 — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 2 checks passed · June 30, 2026
What it owns · $21m
Short-term assets $16mLonger-term assets $5m
What it owes, and who funded it · $21m
Short-term liabilities $2mLonger-term liabilities $2mShareholders' equity $16m
  • Short-term assets cover short-term liabilities $16m of assets due within a year against $2m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $16m short-term assets against $2m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Astrotech Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+2.1%
year over year
R&D spending
381.2%
of revenue
Sales & admin spending
462.8%
of revenue
Days sales outstanding
27 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in life sciences tools & services
Growth, margins and cash generation against peers
Last 12 months unless stated ASTC QSI BGLC YDES ISPC SEER Median
Revenue, last 12 months $2m $2m $3m $596817 $466302 $14m $209m
Revenue growth, last 12 months 62.2% −53.0% −67.3% 16.9% −92.1% −12.7% 6.9%
Revenue growth, 3-year average 31.4% 51.8% −32.9% — −64.1% −5.1% 2.9%
Revenue growth, latest quarter 315.0% −41.8% −96.6% — −78.7% −23.4% 8.5%
Gross margin 12.8% 35.0% 12.3% 28.1% −98.0% 47.7% 50.9%
Operating margin −831.2% <−999% −81.8% −883.3% <−999% −498.2% −16.5%
Operating margin, 3-year average <−999% <−999% −45.3% — −768.0% −575.4% −23.3%
Net margin −848.1% <−999% −82.4% <−999% <−999% −478.0% −20.0%
Cash from operations / revenue −790.9% <−999% −27.1% <−999% <−999% −305.1% 0.7%
Free-cash-flow margin −842.6% <−999% −27.3% <−999% <−999% −311.1% −3.1%
Free-cash-flow margin, 3-year average −920.9% <−999% −29.5% — −549.8% −335.4% −0.4%
Stock pay / revenue 54.1% 693.5% — 75.1% 1.0% 74.3% 4.8%
Change in share count 2.1% 31.2% — 3.1% — 0.2% 1.0%

Median of all 55 companies we cover in life sciences tools & services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Reported value
$1.7M
Institutions reporting
17
Shares held vs prior quarter
▲ 52.2%
Positions opened / closed
4 / 2

Top buyers and sellers, Q2 2026: 7 institutions bought and 8 sold ; the biggest buyer was Jane Street Group, LLC (+55K shares) and the biggest seller T3 Companies, LLC (−13K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Jane Street Group, LLC $597,583 55K 34.8% New
Vanguard Capital Management LLC $243,792 22K 14.2% ▲ 142.9%
Blackrock, Inc. $220,150 20K 12.8% 0.0%
Geode Capital Management, LLC $169,423 16K 9.9% ▼ 19.7%
J. Safra Sarasin Holding AG $140,049 27K 8.2% 0.0%
State Street Corp $120,697 11K 7.0% New
Scs Capital Management LLC $119,955 11K 7.0% ▼ 6.5%
Vanguard Fiduciary Trust Co $86,760 8K 5.1% ▲ 83.4%
Jones Financial Companies LLLP $8,249 1K 0.5% New
Tower Research Capital LLC (TRC) $7,274 1K 0.4% ▼ 70.5%
Morgan Stanley $840 0K 0.0% New
UBS Group AG $698 0K 0.0% ▼ 68.0%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Astrotech Corp's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around December 24, 2026 estimated from the company's past filing pattern, not announced

  • September 25, 2026
  • May 13, 2026
  • February 13, 2026
  • November 13, 2025
  • September 25, 2025
  • May 13, 2025

Recent SEC filings

Data status

When each part of this page on Astrotech Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Astrotech Corp in brief

What does Astrotech Corp do?
Astrotech Corp is a US-listed company in the life sciences tools & services industry. Its financial year ends in June.
What is Astrotech Corp's stock ticker?
Astrotech Corp trades under the ticker ASTC on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Astrotech Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Astrotech Corp reported revenue of $1.7M, 62.2% higher than a year earlier, according to its SEC filings.
What is Astrotech Corp's free cash flow?
Astrotech Corp's free-cash-flow margin is -842.6% of revenue over the trailing twelve months.
Who are Astrotech Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Jane Street Group, LLC, Vanguard Capital Management LLC and Blackrock, Inc. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Astrotech Corp's market cap?
On June 30, 2026, Astrotech Corp's market capitalisation was about $18.5M and net debt of -$8.4M. Market figures come from third-party market data and may be delayed.
Who are Astrotech Corp's competitors?
In our Life Sciences Tools & Services peer group, the companies closest to Astrotech Corp are Quantum-si Inc, Bionexus Gene Lab Corp, YD Bio Ltd, Ispecimen Inc. and Seer, Inc. The side-by-side comparison below sets their revenue, margins and growth against Astrotech Corp's.
When is Astrotech Corp's next earnings date?
Around December 24, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Astrotech Corp announces its own schedule.